Showing results (51-60 of 541) with videos related to
Sort By:
Pageof 55
Toxicology Letters|April 27, 2001
The use of gene knockout mice to unravel the mechanisms of toxicity and chemical carcinogenesisF J GonzalezToxicology Letters|February 18, 1999
The study of xenobiotic-metabolizing enzymes and their role in toxicity in vivo using targeted gene disruptionF J GonzalezToxicology|October 5, 1993
Molecular biology of human xenobiotic-metabolizing cytochromes P450: role of vaccinia virus cDNA expression in evaluating catalytic functionF J GonzalezThe Journal of Pharmacology and Experimental Therapeutics|November 21, 2001
Insights into the mechanisms of ifosfamide encephalopathy: drug metabolites have agonistic effects on alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainate receptors and induce cellular acidification in mouse cortical neuronsJ Y Chatton, J R Idle, C B Vågbø, et al.The British Journal of Psychiatry : the Journal of Mental Science|January 1, 1997
Antipsychotic drug-induced movement disorders in schizophrenics in relation to CYP2D6 genotypeM Armstrong, A K Daly, R Blennerhassett, et al.Movement Disorders : Official Journal of the Movement Disorder Society|December 5, 2000
Allelic association between the DRD2 TaqI A polymorphism and Parkinson's diseaseL Grevle, C Güzey, H Hadidi, et al.Lancet (London, England)|September 17, 1977
Polymorphic hydroxylation of Debrisoquine in manA Mahgoub, J R Idle, L G Dring, et al.European Journal of Cancer (Oxford, England : 1990)|June 1, 1996
Ifosfamide nephrotoxicity: limited influence of metabolism and mode of administration during repeated therapy in paediatricsA V Boddy, M English, A D Pearson, et al.Lancet (London, England)|April 25, 1992
Mutant debrisoquine hydroxylation genes in Parkinson's diseaseM Armstrong, A K Daly, S Cholerton, et al.Pageof 55